Alfonso Galderisi, MD, PhD
he/him/his
Assistant Professor
Biography
Research & Publications
News
Appointments
Biography
Alfonso Galderisi, MD, PhD, is a pediatric endocrinologist who completed his training in Italy at the University of Padova. At the university of Padova he conducted the first trial using continuous glucose monitoring to adjust glucose intakes of very preterm infants, followed by a large Cooperative European Study aimed to identify the effects of early glucose changes on neonatal brain.
During his research fellowship at Yale University in 2016 he worked on the role of the incretins as determinants of beta cell function in children with obesity. More recently, by the use of metabolic modelling, his research focused on the physiopathology of insulin sensitivity and secretion in the early stages of T1D. His research areas include the physiology of insulin secretion and sensitivity in children with T1D and T2D and the early neonatal glucose metabolism. His research had been supported by the European Commission (while he was assistant professor of Pediatrics in Italy) and by the Juvenile Diabetes Research Foundation.
Education & Training
- PhDUniversity of Padova, Pediatric Diabetology (2019)
- Research FellowshipYale School of Medicine (2019)
- Non Degree ProgramUniversity of Padova, Pediatrics (2017)
- ResidencyUniversity of Padova (2017)
- FellowshipUniversity of Padova (2017)
- Research FellowshipLipes Lab, Harvard Medical School – Joslin Diabetes Center (2014)
- MDSecond University of Naples, Medicine (2010)
- InternHarvard Medical School (2009)
Activities
- Transient and Persistent Neonatal Hyperglycemia : mechanisms and therapeutic options.Toronto, ON, Canada 2024Pediatric Academic Societies Meeting (PAS)
- Beta cell function in the early T1D stagesParis, IDF, France 2024Seminaries of Pediatric Endocrinology
- Inhaled Insulinvirtual meeting 2023Diabetes Technology Meeting
- The path to multiple metabolic sensingBethesda, MD, United States 2023Workshop on artificial pancreas
- Beyond the glucose-centric diabetes management: The path to multiple sensingBerlin, BE, Germany 2023Advanced Technologies & Treatments for Diabetes - 16th International Conference
- Big data and artificial intelligence in type 1 diabetesAbu Dhabi, Abu Dhabi, United Arab Emirates 2022International Society Pediatric and Adolescent Diabetes - 48th Annual Conference
- New outcomes in type 1 diabetesRome, Lazio, Italy 2022European Society of Pediatric Endocrinology
- A deeper look into diabetes “before” (T1)diabetesCardiff, Wales, United Kingdom 2022Endocrinology Seminaries - Cardiff University
- The Padova Chart for Health in ChildrenPadua, Veneto, Italy 2022University of Padova 800 Lecture
- Oral Minimal Model Testing Reveals Early Impairment Of Insulin Sensitivity In Type One Diabetes Autoantibody Positive, Non-obese, Non-dysglycemic YouthAmerican Diabetes Association 81st Scientific Session 2021American Diabetes Association
- Glycemic control in preterm neonatesGrand Round Neonatal-Perinatal Medicine 2020Brigham Women Hospital Grand Rounds
- Genetic And Metabolic Determinants Of The Incretin Effect In Obese Adolescent With PrediabetesAmerican Diabetes Association 80th Scientific Session 2020American Diabetes Association
- New Technologies for glucose monitoring in preterm babiesLuxembourg, Luxembourg, Luxembourg 2019Centre Hospitalier de Luxembourg
- Static, but Nondynamic, ß- Cell Responsiveness to Glucose Is Affected by the Risk Variant rs7903146 of TCF7L2 and Associated with a Delayed Time-to-Glucose-Peak in Obese Youths.San Francisco, CA, United States 2019American Diabetes Association 79th Scientific Sessions
- Fructose consumption contributes to hyperinsulinemia in obese adolescents through a GLP-1 mediated mechanism.San Francisco, CA, United States 2019American Diabetes Association 79th Scientific Sessions
- Insulin clearance is an independent determinant of beta-cell function in obese youthsSan Francisco, CA, United States 2019American Diabetes Association 79th Scientific Session
- The TCF7L2 Variant rs7903146 Affects the Risk of Youth-Onset Type 2 Diabetes by Reducing the Incretin Effect on Insulin SecretionOrlando, FL, United States 2018American Diabetes Association
- Increased time spent in euglycemic range in very low birthweight infants by continuous glucose monitoring: a randomized controlled trial.Baltimore, MD, United States 2016Pediatric Academic Societies Meeting (PAS)
- Neonatal Hypoglycemia and Continuous glucose monitoring: a randomized controlled trial in preterm infants.Milan, Lombardy, Italy 2016Advanced Technologies & Treatments for Diabetes
- Minipuberty hormones arousal: the clue for the differential diagnosis of 46,XY DSDSan Francisco, CA, United States 2013Endocrine Society
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| ADA Scientific Sessions Young Investigator Award Recipient | American Diabetes Association | 2022 |
| Young Researcher "R. Balducci" Award - Italian Society Pediatric Endocrinology and Diabetes | Italian Society Pediatric Endocrinology and Diabetes | 2021 |
| ISPAD-JDRF Research Fellowship | International Society Pediatric Adolescent Diabetes | 2016 |
| Albert Renold Fellowship | European Association for the Study of Diabetes (EASD) | 2013 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Diabetologia | Reviewer | 2022 - 2024 |
| The Journal of Pediatrics | Reviewer | 2022 - 2023 |
| Diabetes, Obesity and Metabolism | Reviewer | 2021 - 2024 |
| The Journal of Clinical Endocrinology & Metabolism | Reviewer | 2021 - 2023 |
| Diabetes Care | Reviewer | 2019 - 2024 |
| Diabetes Technology & Therapeutics | Reviewer | 2018 - 2024 |
| International Society for Pediatric and Adolescent Diabetes (ISPAD) | Member | 2012 - 2024 |
| European Society of Pediatric Endocrinology (ESPE) | Member | 2012 - 2024 |